| |
| |
|
| Insider
Information: |
Basil Michelle L |
| Relationship: |
EVP and General Counsel |
| City: |
Braintree |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
31,257 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,780,623 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,257 |
|
|
| Total
Value |
$2,780,623 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.6
|
| Percentage
Gain/Loss : |
0.0%
|
 71.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Haemonetics Corp |
HAE |
EVP and General Counsel |
2024-05-20 |
31,257 |
2017-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2019-10-09 |
4 |
AS |
$122.50 |
$1,318,117 |
D/D |
(10,633) |
13,138 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2019-10-08 |
4 |
AS |
$122.34 |
$1,086,746 |
D/D |
(8,883) |
23,771 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2021-03-08 |
4 |
S |
$120.07 |
$46,227 |
D/D |
(385) |
15,607 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2019-06-12 |
4 |
S |
$109.37 |
$25,264 |
D/D |
(231) |
13,138 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-10-23 |
4 |
S |
$106.58 |
$19,291 |
D/D |
(181) |
15,992 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2019-06-07 |
4 |
AS |
$103.38 |
$743,801 |
D/D |
(7,187) |
13,369 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2019-06-06 |
4 |
AS |
$103.25 |
$634,781 |
D/D |
(6,148) |
15,684 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-05-15 |
4 |
S |
$100.44 |
$20,389 |
D/D |
(203) |
14,161 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-03-09 |
4 |
S |
$98.00 |
$38,710 |
D/D |
(395) |
14,364 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-08 |
4 |
S |
$97.03 |
$66,660 |
D/D |
(687) |
16,376 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2024-05-15 |
4 |
D |
$96.49 |
$40,140 |
D/D |
(416) |
31,856 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2024-05-16 |
4 |
AS |
$96.14 |
$94,698 |
D/D |
(985) |
30,425 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2024-05-17 |
4 |
D |
$95.73 |
$64,043 |
D/D |
(669) |
28,683 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2024-05-20 |
4 |
AS |
$95.08 |
$152,508 |
D/D |
(1,604) |
31,257 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2024-05-17 |
4 |
AS |
$95.00 |
$101,935 |
D/D |
(1,073) |
29,352 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2024-05-16 |
4 |
D |
$94.80 |
$42,281 |
D/D |
(446) |
31,410 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2018-06-07 |
4 |
S |
$92.73 |
$42,378 |
D/D |
(457) |
10,597 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-16 |
4 |
AS |
$90.32 |
$1,223,006 |
D/D |
(13,436) |
16,173 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-12 |
4 |
AS |
$89.29 |
$18,126 |
D/D |
(203) |
40,187 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-05-16 |
4 |
D |
$89.21 |
$39,788 |
D/D |
(446) |
36,010 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-10-20 |
4 |
D |
$89.05 |
$17,543 |
D/D |
(197) |
32,272 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-05-12 |
4 |
D |
$88.16 |
$17,985 |
D/D |
(204) |
32,251 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-15 |
4 |
AS |
$87.71 |
$927,796 |
D/D |
(10,578) |
29,609 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2019-03-07 |
4 |
S |
$83.57 |
$32,676 |
D/D |
(391) |
12,879 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-05-18 |
4 |
D |
$83.34 |
$295,107 |
D/D |
(3,541) |
32,469 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
